Lieber Institute Fills Gap In Neuropsychiatric Research Ecosystem, Seeks Pharma Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
At a time of resurgent interest in CNS, The Lieber Institute for Brain Development’s capabilities and tissue resources set it apart from other brain research initiatives. The privately backed research lab is focused on translating genetic clues to the cause and course of schizophrenia and related disorders into new treatments.